IOVA
NASDAQ · Biotechnology
Iovance Biotherapeutics Inc
$3.73
-0.02 (-0.53%)
Open$3.64
Previous Close$3.75
Day High$3.74
Day Low$3.52
52W High$6.09
52W Low$1.64
Volume—
Avg Volume7.97M
Market Cap1.13B
P/E Ratio—
EPS$-1.20
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+1,368.4% upside
Current
$3.73
$3.73
Target
$54.77
$54.77
$41.45
$54.77 avg
$77.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 226.27M | 337.04M | 333.93M |
| Net Income | -513,269,012 | 23.64M | 18.09M |
| Profit Margin | -226.8% | 7.0% | 5.4% |
| EBITDA | -528,620,309 | 42.24M | 40.52M |
| Free Cash Flow | — | 21.56M | 19.96M |
| Rev Growth | — | +17.4% | +6.9% |
| Debt/Equity | 0.00 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |